Company Filing History:
Years Active: 2002
Title: Elizabeth S. Fleming: Innovator in Antiviral Compounds
Introduction
Elizabeth S. Fleming is a notable inventor based in Belmont, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. Her work focuses on innovative formulations that can potentially treat various viral infections.
Latest Patents
Elizabeth holds a patent for her invention titled "Triazine antiviral compounds." This patent encompasses pharmaceutical formulations that include 1,3,5-triazine derivatives. The compounds and formulations she developed exhibit a range of activities, including antiviral and antibiotic properties. These formulations can be utilized, either alone or in combination, as a method of treating patients in need of antiviral and/or antibiotic therapy. The triazine derivatives bind to and inhibit functional nucleic acids, showcasing broad applicability in treating conditions associated with DNA and RNA viruses. She has been awarded 1 patent for her innovative work.
Career Highlights
Elizabeth is currently associated with Scriptgen Pharmaceuticals, Inc., where she continues to advance her research in antiviral therapies. Her dedication to innovation in pharmaceuticals has positioned her as a key figure in her field.
Collaborations
Elizabeth has collaborated with notable colleagues, including Jaime E. Arenas and Sharon T. Cload. These partnerships have further enriched her research and development efforts.
Conclusion
Elizabeth S. Fleming is a pioneering inventor whose work in antiviral compounds has the potential to make a significant impact in the medical field. Her contributions reflect a commitment to advancing healthcare through innovative pharmaceutical solutions.